Biotech · Private company
Kazia Therapeutics Limited
Track this companyFree. Adds Kazia Therapeutics Limited to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Paxalisib (GDC-0084)Phase 2 · Glioblastoma, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Part A: Dose Escalation of CantrixilPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Part B: Expansion Cohort of CantrixilPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Paxalisib With a High Fat, Low Carb Diet and Metformin for GlioblastomaPHASE2 · COMPLETED · started Feb 14, 2022ClinicalTrials.gov NCT05183204 · fetched Nov 12, 2026
- Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSLPHASE2 · RECRUITING · started Jun 1, 2021ClinicalTrials.gov NCT04906096 · fetched Nov 12, 2026
- Genetic Testing in Guiding Treatment for Patients With Brain MetastasesPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 17, 2019ClinicalTrials.gov NCT03994796 · fetched Nov 12, 2026
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2_PHASE3 · RECRUITING · started Jul 30, 2019ClinicalTrials.gov NCT03970447 · fetched Nov 12, 2026
- GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain MetastasesPHASE2 · TERMINATED · started Feb 25, 2019ClinicalTrials.gov NCT03765983 · fetched Nov 12, 2026
- Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline GliomasPHASE1 · COMPLETED · started Nov 19, 2018ClinicalTrials.gov NCT03696355 · fetched Nov 12, 2026
- Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed GlioblastomaPHASE2 · COMPLETED · started May 15, 2018ClinicalTrials.gov NCT03522298 · fetched Nov 12, 2026
- Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.PHASE1 · COMPLETED · started Dec 5, 2016ClinicalTrials.gov NCT02903771 · fetched Nov 12, 2026